Inhibition of ribonucleotide reductase by alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D004341:Drug Evaluation; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship; D013882:Thiosemicarbazones / Q000494:pharmacology*
D000970:Antineoplastic Agents; D007546:Isoquinolines; D013882:Thiosemicarbazones; C002526:1-formylisoquinoline thiosemicarbazone; C013996:2-formylpyridine thiosemicarbazone; C013118:4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone; D012264:Ribonucleotide Reductases